Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease

FASEB Journal

Volumn 30, Issue 11, 2016, Pages 3853-3859

  Goetzl, Edward J ^a,b   Mustapic, Maja ^a   Kapogiannis, Dimitrios ^a   Eitan, Erez ^a   Lobach, Irina V ^c   Goetzl, Laura ^d   Schwartz, Janice B ^a,b,e   Miller, Bruce L ^f  

^a Department of Medicine ^*  (United States)

^b Center for Evidence based Medicine and Health Outcome Research   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Jewish Home of San Francisco   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid; Biomarkers; Dementia; Tau

Indexed keywords

BETA SECRETASE 1; ENOLASE; GAMMA SECRETASE; GLIAL DERIVED NEUROTROPHIC FACTOR; PROTEIN; SERUM AMYLOID P; TAU PROTEIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BIOLOGICAL MARKER; SECRETASE;

ADULT; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTE DERIVED EXOSOME; CELL COMMUNICATION; CELL INTERACTION; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; MALE; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RETROSPECTIVE STUDY; AGED; BLOOD; FRONTOTEMPORAL DEMENTIA; METABOLISM;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; ASTROCYTES; BIOMARKERS; EXOSOMES; FRONTOTEMPORAL DEMENTIA; HUMANS; NEURONS; TAU PROTEINS;

EID: 84996590165     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600756R     Document Type: Article

References (39)

1. Hochstim, C., Deneen, B., Lukaszewicz, A., Zhou, Q., and Anderson, D. J. (2008) Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell 133, 510-522
2. Farmer, W.T., Abrahamsson, T., Chierzi, S., Lui, C., Zaelzer, C., Jones, E. V., Bally, B. P., Chen, G.G., Theroux, J. F., Peng, J., Bourque, C. W., Charron, F., Ernst, C., Sjöström, P. J., andMurai, K.K. (2016)Neurons diversify astrocytes in the adult brain through sonic hedgehog signaling. Science 351, 849-854
3. Hartlage-Rübsamen, M., Zeitschel, U., Apelt, J., Gärtner, U., Franke, H., Stahl, T., Günther, A., Schliebs, R., Penkowa, M., Bigl, V., and Rossner, S. (2003) Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Glia 41, 169-179
4. Walz, W. (2000) Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int. 36, 291-300
5. Santello, M., and Volterra, A. (2009) Synaptic modulation by astrocytes via Ca2+-dependent glutamate release. Neuroscience 158, 253-259
6. Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J. Y., Takano, H., Moss, S. J., McCarthy, K., and Haydon, P. G. (2005)Astrocytic purinergic signaling coordinates synaptic networks. Science 310, 113-116
7. Ishibashi, T., Dakin, K.A., Stevens, B., Lee, P. R., Kozlov, S.V., Stewart, C. L., and Fields, R. D. (2006) Astrocytes promote myelination in response to electrical impulses. Neuron 49, 823-832
8. Wyss-Coray, T., Loike, J.D., Brionne, T.C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., and Husemann, J. (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9, 453-457
9. Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., and Paul, S. M. (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10, 719-726
10. Abramov, A. Y., Canevari, L., and Duchen, M. R. (2004) Beta-Amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 24, 565-575
11. Matos, M., Augusto, E., Oliveira, C. R., and Agostinho, P. (2008) Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-Activated protein kinase cascades. Neuroscience 156, 898-910
12. Multhaup, G., Huber, O., Búee, L., and Galas, M. C. (2015) Amyloid precursor protein (APP) metabolites APP intracellular fragment (AICD), Ab42, and tau in nuclear roles. J. Biol. Chem. 290, 23515-23522
13. Zhao, J., O'Connor, T., and Vassar, R. (2011) The contribution of activated astrocytes to Ab production: implications for Alzheimer's disease pathogenesis. J. Neuroinflammation 8, 150
14. Hong, H. S., Hwang, E. M., Sim, H. J., Cho, H. J., Boo, J.H., Oh, S. S., Kim, S. U., and Mook-Jung, I. (2003) Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes. Biochem. Biophys. Res. Commun. 307, 922-927
15. Christensen, M.A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., and Song, W. (2004) Transcriptional regulation of BACE1, the beta-Amyloid precursor protein beta-secretase, by Sp1. Mol. Cell. Biol. 24, 865-874
16. Mei, Z., Yan, P., Tan, X., Zheng, S., and Situ, B. (2015)Transcriptional regulation of BACE1 by NFAT3 leads to enhanced amyloidogenic processing. Neurochem. Res. 40, 829-836
17. Natunen, T., Takalo, M., Kemppainen, S., Leskelä, S., Marttinen, M., Kurkinen, K. M., Pursiheimo, J. P., Sarajärvi, T., Viswanathan, J., Gabbouj, S., Solje, E., Tahvanainen, E., Pirttimäki, T., Kurki, M., Paananen, J., Rauramaa, T., Miettinen, P., Mäkinen, P., Leinonen, V., Soininen, H., Airenne, K., Tanzi, R. E., Tanila, H., Haapasalo, A., and Hiltunen, M. (2016) Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Neurobiol. Dis. 85, 187-205
18. Kurkinen, K.M., Marttinen, M., Turner, L., Natunen, T., Makinen, P., Haapalinna, F., Sarajarvi, T., Gabbouj, S., Kurki, M., Paananen, J., Koivisto, A.M., Rauramaa, T., Leinonen, V., Tanila, H., Soininen, H., Lucas, F. R., Haapasalo, A., and Hiltunen, M. (2016) SEPT8 modulates beta-Amyloidogenic processing of APP via affecting the sorting and accumulation of BACE1. J. Cell Sci. 129, 2224-2238
19. Liao, M. C., Muratore, C. R., Gierahn, T. M., Sullivan, S. E., Srikanth, P., De Jager, P. L., Love, J. C., and Young-Pearse, T. L. (2016) Singlecell detection of secreted Ab and sAPPa from human IPSC-derived neurons and astrocytes. J. Neurosci. 36, 1730-1746
20. Rajendran, L., Bali, J., Barr, M.M., Court, F. A., Krämer-Albers, E.M., Picou, F., Raposo, G., van der Vos, K. E., van Niel, G., Wang, J., and Breakefield, X. O. (2014) Emerging roles of extracellular vesicles in the nervous system. J. Neurosci. 34, 15482-15489
21. Budnik, V., Ruiz-Cañada, C., and Wendler, F. (2016) Extracellular vesicles round off communication in the nervous system. Nat. Rev. Neurosci. 17, 160-172
22. Goetzl, E. J., Boxer, A., Schwartz, J. B., Abner, E. L., Petersen, R. C., Miller, B. L., andKapogiannis, D. (2015) Alteredlysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85, 40-47
23. Kapogiannis, D., Boxer, A., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U., Frassetto, L., Petersen, R. C., Miller, B. L., and Goetzl, E. J. (2015) Dysfunctionally phosphorylated type 1 insulin receptor substrate inneural-derived bloodexosomes of preclinical Alzheimer's disease. FASEB J. 29, 589-596
24. Petersen, R. C. (2004) Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183-194
25. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A.M., Iwatsubo, T., Jack, C.R., Jr., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., Wagster, M. V., and Phelps, C. H. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280-292
26. Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P. J., and Scheltens, P. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6, 734-746
27. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944
28. Alzheimer's Disease Neuroimaging Initiative. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann. Neurol. 65, 403-413
29. Irizarry, M. C., Webb, D. J., Bains, C., Barrett, S. J., Lai, R. Y., Laroche, J. P., Hosford, D., Maher-Edwards, G., and Weil, J. G. (2008) Predictors of placebo group decline in the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease. J. Alzheimers Dis. 14, 301-311
30. Cano, S. J., Posner, H. B., Moline, M. L., Hurt, S. W., Swartz, J., Hsu, T., andHobart, J.C. (2010)TheADAS-cog inAlzheimer'sdiseaseclinical trials: psychometric evaluation of the sum and its parts. J. Neurol. Neurosurg. Psychiatry 81, 1363-1368
31. Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G., Onyike, C. U., Hillis, A. E., Josephs, K. A., Boeve, B. F., Kertesz, A., Seeley, W.W., Rankin, K. P., Johnson, J. K., Gorno-Tempini, M. L., Rosen, H., Prioleau-Latham, C. E., Lee, A., Kipps, C. M., Lillo, P., Piguet, O., Rohrer, J. D., Rossor, M. N., Warren, J. D., Fox, N. C., Galasko, D., Salmon, D. P., Black, S. E., Mesulam, M., Weintraub, S., Dickerson, B. C., Diehl-Schmid, J., Pasquier, F., Deramecourt, V., Lebert, F., Pijnenburg, Y., Chow, T.W., Manes, F., Grafman, J., Cappa, S. F., Freedman, M., Grossman, M., andMiller, B. L. (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456-2477
32. Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J.M., Rohrer, J. D., Black, S., Boeve, B. F., Manes, F., Dronkers, N. F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B. L., Knopman, D. S., Hodges, J. R., Mesulam, M.M., andGrossman, M. (2011)Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014
33. Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., andGoetzl, E. J. (2015) Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 11, 600-607
34. Mattson, M. P., Barger, S. W., Begley, J. G., and Mark, R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216
35. Chojnacki, A., and Weiss, S. (2008) Production of neurons, astrocytes and oligodendrocytes frommammalian CNS stem cells. Nat. Protoc. 3, 935-940
36. Hol, E. M., Roelofs, R. F., Moraal, E., Sonnemans, M. A., Sluijs, J. A., Proper, E. A., deGraan, P. N., Fischer, D. F., and van Leeuwen, F. W. (2003) Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol. Psychiatry 8, 786-796
37. Bi, B., Salmaso, N., Komitova, M., Simonini, M. V., Silbereis, J., Cheng, E., Kim, J., Luft, S., Ment, L. R., Horvath, T. L., Schwartz, M. L., and Vaccarino, F.M. (2011) Cortical glial fibrillary acidic protein-positive cells generate neurons after perinatal hypoxic injury. J. Neurosci. 31, 9205-9221
38. Tieu, P. T., Bach, G., Matynia, A., Hwang, M., and Neufeld, E. F. (1995) Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S). Hum. Mutat. 6, 55-59
39. Ruth, L., Eisenberg, D., andNeufeld, E. F. (2000) alpha-L-iduronidase forms semi-crystalline spherulites with amyloid-like properties. Acta Crystallogr. D Biol. Crystallogr. 56, 524-528